<DOC>
	<DOCNO>NCT01416441</DOCNO>
	<brief_summary>The goal current trial obtain long term efficacy , safety tolerability data Once weekly aripiprazole child adolescents Tourette 's Disorder .</brief_summary>
	<brief_title>Safety &amp; Tolerability Study Once-weekly Oral Aripiprazole Children Adolescents With Tourette 's Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Tourette Syndrome</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Completed participation discontinue due lack efficacy week 5 later either Trial 3110272 3110273 Written ICF obtain legally acceptable representative &amp; informed assent Baseline applicable trial center 's IRB/IEC The subject , designate guardian ( ) caregiver ( ) able comprehend satisfactorily comply protocol requirement , evaluate investigator . The subject experience AEs doubleblind trial ( 3110272 3110273 ) would , investigator 's judgment , preclude exposure aripiprazole . The subject protocol violation doubleblind trial consider major judgment investigator would deem subject poor candidate trial A positive drug screen baseline cocaine , alcohol drug abuse result early termination Week 1 Sexually active patient use 2 approved method contraception ; breastfeed pregnant . Risk commit suicide Body weight low 16 kg Abnormal laboratory test result , vital sign ECG result</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Tourette 's Disorder</keyword>
	<keyword>tic disorder</keyword>
</DOC>